| Prev Close | 14.45 |
| Open | 14.50 |
| Day Low/High | 14.10 / 14.75 |
| 52 Wk Low/High | 13.23 / 16.45 |
| Volume | 176.31K |
| Avg Volume | 296.30K |
| Exchange | NASDAQ |
| Shares Outstanding | 42.31M |
| Market Cap | 615.58M |
| EPS | 0.50 |
| P/E Ratio | 28.53 |
| Div & Yield | 0.50 (3.39%) |
In recent trading, shares of Meridian Bioscience Inc. have crossed above the average analyst 12-month target price of $15.00, changing hands for $15.05/share.
The most recent short interest data was recently released for the 01/12/2018 settlement date, and Meridian Bioscience Inc. is one of the most shorted stocks of the Russell 3000, based on 13.90 "days to cover" versus the median component at 4.53.
Looking at the universe of stocks we cover at Dividend Channel, on 2/2/18, Meridian Bioscience Inc. will trade ex-dividend, for its quarterly dividend of $0.125, payable on 2/15/18.
Former Attorney General of Louisiana, Charles C. Foti, Jr.
Former Attorney General of Louisiana, Charles C. Foti, Jr.
Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether certain directors and officers of Meridian Bioscience, Inc.
The Klein Law Firm reminds shareholders that a class action complaint has been filed on behalf of shareholders of Meridian Bioscience, Inc.
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of investors who purchased Meridian Bioscience, Inc.
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of...
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Meridian Bioscience, Inc.
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Meridian Bioscience, Inc.
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of investors who purchased Meridian Bioscience, Inc.
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of...
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Meridian Bioscience, Inc.
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Meridian Bioscience, Inc.
The Klein Law Firm announces the commencement of an investigation of Meridian Bioscience, Inc.
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Meridian Bioscience, Inc.
Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Meridian Bioscience, Inc.
The Klein Law Firm announces the commencement of an investigation of Meridian Bioscience, Inc.
The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Meridian Bioscience, Inc.
Looking at the universe of stocks we cover at Dividend Channel, on 11/17/17, Meridian Bioscience Inc. will trade ex-dividend, for its quarterly dividend of $0.125, payable on 11/30/17.
The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 467,627 share decrease in total short interest for Meridian Bioscience Inc. , to 3,145,924, a decrease of 12.94% since 10/13/2017.
